|
11 |
Proposal for a descriptive and differentiated presentation of the longitudinal impact of the new organized cancer screening guideline and HPV vaccination in Germany
Enthalten in Archives of gynecology and obstetrics 2.9.2022: 1-12
|
|
|
|
12 |
The impact of rehabilitation sport on breast cancer-related lymphoedema and quality of life
Enthalten in Archives of gynecology and obstetrics 26.7.2022: 1-9
|
|
|
|
13 |
Belastung von Betroffenen mit MRKH-Syndrom: Effekt einer Intervention zur Unterstützung bei Neovagina-Anlage
Enthalten in Psychotherapie, Psychosomatik, medizinische Psychologie 03.05.2022
|
|
|
|
14 |
Opinion paper: gynecological surgery in local anesthesia?
Enthalten in Archives of gynecology and obstetrics 29.4.2022: 1-6
|
|
|
|
15 |
Einsatz eines Wendelappens zur Wiederherstellung des Volumens im Achselbereich – ein neuer Behandlungsansatz für die operative Versorgung von sekundären Lymphödemen nach Brustkrebstherapie
Enthalten in Senologie Bd. 18, 2021, Nr. 03: 266-272
|
|
|
|
16 |
Challenges and Opportunities for Real-World Evidence in Metastatic Luminal Breast Cancer
Enthalten in Breast care Bd. 16, 2021, Nr. 2: 108-114. 7 S.
|
|
|
17 |
DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs)
Singh, Yogesh. - Aachen : Universitätsbibliothek der RWTH Aachen, 2020
|
|
|
|
18 |
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
Hübner, Hanna. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2020
|
|
|
|
19 |
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany
Hübner, Hanna. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2020
|
|
|
|
20 |
Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer — Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany
Schneeweiss, Andreas. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2020
|
|
Administration
